Document Detail

Leukocytosis and high hematocrit levels during abdominal attacks of hereditary angioedema.
Jump to Full Text
MedLine Citation:
PMID:  23915279     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
BACKGROUND: The diagnosis of hereditary angioedema (HAE) is often delayed due to the low awareness of this condition. In patients with undiagnosed HAE, abdominal symptoms often create the risk of unnecessary surgical operation and/or drug therapy. To explore the cause of misdiagnosis, we compared the laboratory findings of HAE patients under normal conditions with those during abdominal attacks.
METHODS: Patient medical histories were analyzed and laboratory data at the first consultation with no symptoms and no medication were compared with those at visits to the emergency department during severe attacks.
RESULTS: Fourteen HAE patients were enrolled. Initial HAE symptoms occurred at 20.2 ± 9.4 years of age. The correct diagnosis of HAE was made 22.7 ± 14.2 years after the initial symptoms. A common site of angioedema was the extremities. Half of the patients experienced a life-threatening laryngeal attack and/or severe abdominal pain. In the patients with severe abdominal pain, significant leukocytosis with neutrophilia along with increased levels of hematocrit were observed while levels of C-reactive protein (CRP) remained low. All severe attacks were alleviated with an infusion of C1-inhibitor concentrate.
CONCLUSIONS: Consideration of the likelihood of a HAE attack is important when patients present with acute abdominal pain and leukocytosis without elevation of CRP.
Authors:
Isao Ohsawa; Seiji Nagamachi; Hiyori Suzuki; Daisuke Honda; Nobuyuki Sato; Hiroyuki Ohi; Satoshi Horikoshi; Yasuhiko Tomino
Related Documents :
23830959 - Long-term morbidity and mortality of carotid endarterectomy in patients with end-stage ...
24051989 - Serum adiponectin, anemia and left ventricular dimensions in patients with cardiac cach...
23006459 - Minimal hepatic encephalopathy in patients with cirrhosis by measuring liver stiffness ...
25024019 - The value of diaphragmatic breathing in the patient with obstructive airways disease.
23672449 - Traumatic thalamic injury demonstrated by diffusion tensor tractography of the spinotha...
25021969 - Ptu-096 cost efficiency of faecal calprotectin in assessing new referrals with altered ...
18022259 - Fibrinogen synthesis is increased in cachectic patients with chronic heart failure.
10718279 - Total dose iron infusion: safety and efficacy in predialysis patients.
9151329 - Brain perfusion spect abnormalities in neuronal ceroid lipofuscinoses.
Publication Detail:
Type:  Journal Article     Date:  2013-08-02
Journal Detail:
Title:  BMC gastroenterology     Volume:  13     ISSN:  1471-230X     ISO Abbreviation:  BMC Gastroenterol     Publication Date:  2013  
Date Detail:
Created Date:  2013-08-06     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100968547     Medline TA:  BMC Gastroenterol     Country:  England    
Other Details:
Languages:  eng     Pagination:  123     Citation Subset:  IM    
Affiliation:
Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan. yasu@juntendo.ac.jp.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): BMC Gastroenterol
Journal ID (iso-abbrev): BMC Gastroenterol
ISSN: 1471-230X
Publisher: BioMed Central
Article Information
Download PDF
Copyright ©2013 Ohsawa et al.; licensee BioMed Central Ltd.
open-access:
Received Day: 18 Month: 10 Year: 2012
Accepted Day: 26 Month: 7 Year: 2013
collection publication date: Year: 2013
Electronic publication date: Day: 2 Month: 8 Year: 2013
Volume: 13First Page: 123 Last Page: 123
PubMed Id: 23915279
ID: 3735392
Publisher Id: 1471-230X-13-123
DOI: 10.1186/1471-230X-13-123

Leukocytosis and high hematocrit levels during abdominal attacks of hereditary angioedema
Isao Ohsawa1 Email: iohsawa@juntendo.ac.jp
Seiji Nagamachi1 Email: snagama@juntendo.ac.jp
Hiyori Suzuki1 Email: hiyori@juntendo.ac.jp
Daisuke Honda1 Email: dhonda@juntendo.ac.jp
Nobuyuki Sato1 Email: nobsato@juntendo.ac.jp
Hiroyuki Ohi2 Email: ohi@h8.dion.ne.jp
Satoshi Horikoshi1 Email: satoshi@juntendo.ac.jp
Yasuhiko Tomino1 Email: yasu@juntendo.ac.jp
1Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan
2Internal Medicine, Tsurumi-Nishiguchi Hospital, Kanagawa, Japan

Background

Hereditary angioedema (HAE) is an autosomal dominant disease, caused by an inherited deficiency of functionally active C1 inhibitor (C1-INH). Episodic local angioedema is due to the release of bradykinin from high molecular weight kininogen via activation of the contact system which increases vascular permeability during HAE attacks [1]. Clinically, HAE is characterized by the presence of subcutaneous or submucosal tissue swelling, usually affecting the face, extremities, upper airways and/or gastrointestinal tract (GI-tract) [2].

While HAE is known to be inherited in an autosomal dominant form, 20-30% of cases develop as a result of de novo mutation [3]. The prevalence of this disease has been estimated at 1 case per 50,000 people, with no reported bias in different ethnic groups [1,3,4]. Plasma-derived C1-INH concentrate has been the first-line treatment for acute HAE attacks for decades, however, new drugs, such as a bradykinin B2 receptor antagonist and a kallikrein inhibitor are available in some countries [2]. Despite the availability of treatments for HAE, the global disease recognition rate is low. We previously conducted a recognition survey of HAE among Japanese physicians: 55% of all responding physicians (n = 4,495) failed to recognize HAE and 11% overlooked or misdiagnosed their patients [5]. Recently, we established a HAE Information Center on the Internet [6] (in Japanese), which aims to promote the recognition of HAE.

When severe edema develops in the airways, a patient’s condition may become life-threatening. When the GI-tract is involved in a HAE attack, edema of the gastrointestinal walls causes abdominal pain, nausea, vomiting and intestinal obstruction which is sometimes similar to that of an acute abdomen and is difficult to distinguish from a surgical emergency [7]. To date, no detailed observations are available which describe the laboratory data in HAE patients having abdominal attacks. In this study, HAE patients were followed and the laboratory findings of patients with no symptoms versus those with critical abdominal attacks were retrospectively compared.


Methods

At the outpatient clinic of Juntendo University Hospital, Tokyo, Japan, HAE patients were followed from January 2011 to August 2012. They were diagnosed based on their clinical histories and laboratory data (antigenic levels of C4 and functional levels of C1-INH). As the evaluation of the antigenic level of C1-INH is not approved by the Japanese health insurance system, the HAE diagnosis criteria described by Agostoni et al. [8] was used for these patients. The study was conducted in accordance with the Declaration of Helsinki (1964) and was approved by the Institutional Review Board at Juntendo University. Written informed consent was obtained from all participating patients.

Family and past medical histories were collected from patients’ medical records. Blood samples were obtained after each patient’s first consultation for differential diagnosis of angioedema under normal conditions (no swelling or medication). All blood samples were obtained from the antecubital vein and biochemical analyses, including white blood cells (WBC), hemoglobin, hematocrit (Hct), serum creatinine, total protein, albumin, immunoglobulin (Ig) G, IgA, IgM, C3, C4, total hemolytic complement (CH50), C-reactive protein (CRP), anti-nuclear antibody (ANA), and immune complex (C1q-binding assay) were performed. Functional levels of C1-INH were determined using a chromogenic assay (Sysmex, Hyogo, Japan). Blood was donated by 10 of 14 patients for determining the antigenic level of C1-INH which was evaluated using nepherometry with antisera to C1-INH (Dade Behring, Inc., Illinois, America). When patients presented at the emergency department with a severe attack, the following laboratory data were re-evaluated: blood counts, WBC, C3, C4, CH50 and CRP in sera. Abdominal computed tomography (A-CT) and ultrasonography were performed as needed. Based on the physicians’ decision, 20 U/kg bodyweight (bw) C1-INH concentrate (Berinert® P, CSL Behring K.K.) was administered intravenously. No patients received prophylactic treatment with drugs such as androgens, kallikrein inhibitor and bradykinin B2 receptor antagonist throughout their clinical passage.

The GraphPad Prism 5J software for Windows (version 5.04; GraphPad, San Diego, CA, USA) was used for statistical analysis, and the two-sided p-value < 0.05 was taken as the level for statistical significance. All data were expressed as mean ± standard deviation (SD).


Results

Fourteen patients with HAE (5 men and 9 women) visited our outpatient clinic. The mean (±SD) age was 44.1 ± 14.4 years. Initial HAE symptoms occurred at 20.2 ± 9.4 years of age, with a delay in correct diagnosis of HAE of 22.7 ± 14.2 years after the initial symptoms. A family history of angioedema was noted in 12 of the 14 patients (86%). All of the patients had experienced self-limiting, noninflammatory subcutaneous angioedema without major urticarial rash, often recurrent and often lasting for more than 12 hours. Trauma, dental procedure and stress could have been the triggering episode, but many attacks occurred without an identifiable stimulus. The frequencies of episodic swelling varied between patients. Swelling of extremities was a common symptom but the affected organs varied by patient. Almost all attacks spontaneously resolved within one hour to three days, however, six patients (No. 1, 6, 7, 8, 9, and 12) experienced a recurrent life-threatening laryngeal attack and/or severe abdominal pain. These severe symptoms had been misinterpreted as allergies, asthma, appendicitis, GI-tract perforation, GI-tract bleeding and/or enterocolitis. Two patients (No. 1 and 6) had previously undergone tracheotomy because of airway obstruction. Three patients had received abdominal surgery due to appendicitis, an ovarian cyst and myoma.

Table 1 shows laboratory data of results obtained on the first visit to our outpatient clinic (when there were no symptoms). Serum levels of C3 were within or above the normal range (69-128 mg/dL) in all but one patient (No. 14) while levels of C4 were below the normal range (14-36 mg/dL) in all cases. Functional levels of C1-INH were also below the normal range (70-130%) in all patients. Therefore, all patients fulfilled the criteria for the diagnosis of HAE [8]. One patient (No.11) had a weakly positive ANA titer (1:80) while all others were negative. Four patients (No. 2, 4, 9, and 10) gave positive results for immune complex, but their first symptoms of angioedema had occurred before the age of 15 years and they had no clinical symptoms of autoimmune diseases.

A total of 31 visits to the emergency department were recorded (Table 2). Of these, 28 were due to severe attacks and the patients were treated with C1-INH concentrate (20 U/kg bw). C1-INH concentrate therapy was effective in alleviating symptoms and all patients returned home without hospital admission. Relatively mild attacks (foot and lips) either received no medication or were treated with tranexamic acid.

Severe colicky abdominal pain was observed a total of 17 times in six of 14 patients. Figure 1(a-d) shows representative A-CT images of a patient (aged 33 years, male) with thickening of the gastrointestinal wall and ascites. The stomach was distended due to a GI-tract obstruction.

The number of WBCs at the time of severe abdominal attack was higher (12,253 ± 3,148 /μL) than those under normal conditions (6,400 ± 1,740 /μL) [p < 0.01] and during attacks involving other sites (6,942 ± 1,393 /μL) [p < 0.01]. However, the levels of CRP were low during normal conditions, abdominal attacks and attacks at other sites (Figure 2). The number of red blood cells at the time of severe abdominal attack (527 ± 50 ×104/μL) was higher than that under normal conditions (459 ± 42×104/μL) [p < 0.01]. The level of Hct at the time of severe abdominal attack (46.1 ± 3.0%) was higher than that under normal conditions (41.7 ± 2.8%) [p < 0.01]. The percentage of neutrophils was higher at the time of severe abdominal attack compared with that under normal conditions (84.1 ± 6.9% versus 61.2 ± 13.2%, respectively; [p < 0.01]) [Figure 3].


Discussion

While the actual diagnosis of HAE is commonly made in the second or third decade of life, symptoms often begin earlier. As the symptoms of HAE mimic other disorders they are often misinterpreted [8]. An international consensus algorithm for the diagnosis of HAE [9] and a Japanese guideline of HAE [10] have been published and describe the determination of antigenic levels of C1-INH as needed for the classification of HAE into type I or type II. However, Japanese health insurance limitations have created a problem in this evaluation. In our study, taking a detailed history of the recurrent angioedema as well as a family history was helpful for suspecting HAE. The detection of low levels of C4 is the key test for screening HAE patients. Our examination confirmed the diagnosis of HAE in 100% of patients by measuring functional levels of C1-INH and serum levels of C4 (normal levels of C4 virtually exclude HAE) [9,11,12]. Although a small number of patients were enrolled in this study, the gender ratio and number of patients with a family history of angioedema were comparable with previous reports [1,3,9].

Frank et al. reported that abdominal pain, nausea and vomiting are the dominant symptoms of HAE in approximately 70-80% of all patients and typically ameliorate within five days [13]. Furthermore, approximately one-third of patients with abdominal attacks undergo unnecessary surgery, such as appendectomy and exploratory laparotomy [14]. Since these abdominal symptoms are relatively nonspecific, the response to treatment with C1-INH concentrate may be the only way to differentiate a HAE attack from a surgical condition [15].

In this study patients visited the emergency department 31 times: 28 of the 31 attacks were severe and treated with C1-INH concentrate which is the only licensed HAE therapy in Japan. After treatment, all symptoms resolved without any side effects and all patients were able to return home.

To date, there has only been one case report describing the occurrence of leukocytosis during an abdominal HAE attack [16]. In our study, the number of WBCs in patients with abdominal attacks was significantly higher than those under normal conditions and during attacks at other sites, while serum levels of CRP showed no significant difference. Although no statistical correlation was observed between attack duration and the number of WBCs, in all cases where an attack had started over 8 hours before the emergency department visit, the number of WBCs was over 12,000 μL. In the context of a usual bacterial infection, leukocytosis is recognized prior to an increase of CRP. Such a situation mimics the super-acute state of a GI-tract infection (e.g., appendicitis) and/or gastrointestinal perforation; however, our patients’ symptoms were alleviated without antibiotics. The main population of WBCs showed increased neutrophils without an increase of CRP. We have not addressed the mechanisim of alteration of the WBC population, although it is possible to envisage a scenario in which these findings demonstrate an unexpected role for the sympathetic nervous system. The number of neutrophils is known to be altered in the response to non-pathologic situations such as emotional or physical stressors [17]. These mechanisms are explained by the β-adrenergic effect of epinephrine, which diminishes neutrophil adherence to the endothelial cells [18,19].

When HAE patients presented with severe abdominal pain, we also found a significant increase in Hct. Simultaneously, the levels of total protein and albumin in sera tended to increase during abdominal attacks (data not shown) but lacked significance. Since red blood cells cannot pass through capillary walls, we could obtain a statistically significant difference. Our previous report also presented a case of severe angioedema which had spread to the patient’s whole body, contributing to a weight gain of nearly 20 kg [20]. It appears that dehydration and the fluctuation of Hct reflects massive fluid translocation from the blood stream to the GI-tract wall. If angioedema could not be alleviated, these severe cases would register hypovolemic shock from extravascular fluid loss [21] and mimic GI-tract bleeding or vagotonic shock due to intolerable pain.


Conclusions

During abdominal attacks in patients with HAE, leukocytosis and high Hct without CRP elevation can be confused with an acute abdomen needing an emergency surgical procedure. Thus, consideration of the likelihood of a HAE attack is of clinical importance in such cases.


Competing interests

None of the authors have any financial or non-financial competing interests influencing the interpretation of data or presentation of information.


Authors’ contributions

IO followed up patients and carried out the study. SN, HS and DH performed the experiments and helped to draft the manuscript. IO and NS designed the study and carried out the statistical analysis. HO, SH and YT revised the manuscript. YT is the corresponding author. All authors read and approved the final manuscript.


Pre-publication history

The pre-publication history for this paper can be accessed here:

http://www.biomedcentral.com/1471-230X/13/123/prepub


Acknowledgments

The authors have not received grant support for this work. We thank to Dr. Yoko Fujimaki (Department of Otorhinolaryngology, Social Insurance Chuo General Hospital), Dr. Akira Yoshida (Department of Emergency Medicine, Kanto Rosai Hospital), Dr. Norihito Hosoi (Department of Surgery, Tokyo-Kita Social Insurance Hospital), Tsunemichi Takeuchi (Department of Dermatology, Jikei University Kashiwa Hospital), Dr. Tadamitsu Morimoto (Department of Otorhinolaryngology, Tokyo Dental College Ichikawa General Hospital), Dr. Takashi Inozume (Department of Dermatology, Faculty of Medicine, University of Yamanashi), Dr. Sayaka Muramatsu (Department of Otorhinolaryngology, Takashimadaira Central General Hospital), Dr. Kenichiro Sekikawa (Department of Gastroenterology, Tokyo Teishin Hospital), and Dr. Takayuki Otoshi (Otoshi Naika Clinic) for their introduction of HAE patients to our outpatient clinic. We also thank Ms. Maiko Nakatsuka and Mr. Masahiro Matsumoto for providing Berinert® P for emergency use.


References
Zuraw BL,Clinical practice. Hereditary angioedemaN Engl J MedYear: 2008131027103610.1056/NEJMcp080397718768946
Bork K,Meng G,Staubach P,Hardt J,Hereditary angioedema: new findings concerning symptoms, affected organs, and courseAm J MedYear: 20061326727410.1016/j.amjmed.2005.09.06416490473
Pappalardo E,Cicardi M,Duponchel C,Carugati A,Choquet S,Agostoni A,Tosi M,Frequent de novo mutations and exon deletions in the C1 inhibitor gene of patients with angioedemaJ Allergy Clin ImmunolYear: 2000131147115410.1067/mai.2000.11047111112899
Yamamoto T,Horiuchi T,Miyahara H,Yoshizawa S,Maehara J,Shono E,Takamura K,Machida H,Tsujioka K,Kaneko T,Uemura N,Suzawa K,Inagaki N,Umegaki N,Kasamatsu Y,Hara A,Arinobu Y,Inoue Y,Niiro H,Kashiwagai Y,Harashima S,Tahira T,Tsukamoto H,Akashi K,Hereditary angioedema in Japan: genetic analysis of 13 unrelated casesAm J Med SciYear: 20121321021410.1097/MAJ.0b013e31822bdb6521934598
Ohsawa I,Nagamachi S,Kusaba G,Ishii M,Sato N,Onda K,Suzuki H,Ohi H,Tomino Y,Hereditary angioedema recognition survey in JapanPharma MedicaYear: 201113109118
HAE information center http://www.hae-info.jp/.
Talavera A,Larraona JL,Ramos JL,Lopez T,Maraver A,Arias J,Barrios A,Hereditary angioedema: an infrequent cause of abdominal pain with ascitesAm J GastroenterolYear: 1995134714747872288
Agostoni A,Aygören-Pürsün E,Binkley KE,Blanch A,Bork K,Bouillet L,Bucher C,Castaldo AJ,Cicardi M,Davis AE,De Carolis C,Drouet C,Duponchel C,Farkas H,Fáy K,Fekete B,Fischer B,Fontana L,Füst G,Giacomelli R,Gröner A,Hack CE,Harmat G,Jakenfelds J,Juers M,Kalmár L,Kaposi PN,Karádi I,Kitzinger A,Kollár T,et al. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyondJ Allergy Clin ImmunolYear: 200413S51S13110.1016/j.jaci.2004.06.04715356535
Bowen T,Cicardi M,Farkas H,Bork K,Longhurst HJ,Zuraw B,Aygoeren-Pürsün E,Craig T,Binkley K,Hebert J,Ritchie B,Bouillet L,Betschel S,Cogar D,Dean J,Devaraj R,Hamed A,Kamra P,Keith PK,Lacuesta G,Leith E,Lyons H,Mace S,Mako B,Neurath D,Poon MC,Rivard GE,Schellenberg R,Rowan D,Rowe A,et al. International consensus algorithm for the diagnosis, therapy and management of hereditary angioedemaAllergy Asthma ImmunolYear: 20101362437
Horiuchi T,Ohi H,Ohsawa I,Fujita T,Matsushita M,Okada N,Seya T,Yamamoto T,Endo Y,Hatanaka M,Wakamiya N,Mizuno M,Nakao M,Okada H,Tsukamoto H,Matsumoto M,Inoue N,Nonaka M,Kinoshita T,Guideline for Hereditary Angioedema (HAE) 2010 by the Japanese Association for Complement ResearchAllergol InternYear: 20121355956210.2332/allergolint.12-RAI-0471
Atkinson JP,Diagnosis and management of hereditary angioedema (HAE)Ann AllerYear: 197913348353
Carugati A,Pappalardo E,Zingale LC,Cicardi M,C1-inhibitor deficiency and angioedemaMol ImmunolYear: 20011316117310.1016/S0161-5890(01)00040-211532278
Frank MM,Hereditary angioedema: the clinical syndrome and its management in the United StatesImmunol Allergy Clin North AmYear: 20061365366810.1016/j.iac.2006.09.00517085283
Gompels MM,Lock RJ,Abinun M,Bethune CA,Davies G,Grattan C,Fay AC,Longhurst HJ,Morrison L,Price A,Price M,Watters D,C1 inhibitor deficiency: consensus documentClin Exp ImmunolYear: 20051337939410.1111/j.1365-2249.2005.02726.x15730382
Cicardi M,Bergamaschini L,Cugno M,Beretta A,Zingale LC,Colombo M,Agostoni A,Pathogenetic and clinical aspects of C1 inhibitor deficiencyImmunobiologyYear: 19981336637610.1016/S0171-2985(98)80041-79777420
Calbo L,Quattrocchi P,Ferlazzo B,Abdominal attack of hereditary angioedema associated with marked leucocytosis: a case reportItal J GastroenterolYear: 1992134644651421450
McCarthy DA,Dale MM,The leukocytosis of exercise. A review and modelSports MedYear: 19881333336310.2165/00007256-198806060-000023068772
Nagatomi R,The implication of alterations in leukocyte subset counts on immune functionExerc Immunol RevYear: 200613547117201072
Gosain A,Gamelli RL,DiPietro LA,Norepinephrine-mediated Suppression of Phagocytosis by Wound NeutrophilsJ Surg ResYear: 20091331131810.1016/j.jss.2008.05.00118952237
Ohsawa I,Satomura A,Fuke Y,Hidaka M,Endo M,Fujita T,Ohi H,Worsening fluid retention in a patient with hereditary angioedema and end-stage renal diseaseInt MedYear: 20041370871210.2169/internalmedicine.43.708
Frank MM,Gelfand JA,Atkinson JP,Hereditary angioedema: the clinical syndrome and its managementAnn Intern MedYear: 19761358059310.7326/0003-4819-84-5-5801275365

Figures

[Figure ID: F1]
Figure 1 

Enhanced abdominal computed tomography (A-CT) of severe gastrointestinal edema. a: Liver-stomach level slice, b: Kidney level slice, c: Under umbilical level slice, d: Pelvis level slice. Patient No. 3 visited the emergency department because of severe abdominal pain and vomiting. Obstructive duodenum (arrow) of the small intestine (arrow head) was visualized due to the thickening of the gastrointestinal walls. Gastric (*) and intestinal walls (‡) were expanded. Moderate ascites was observed around liver (†). (Photos were provided by Dr. N. Hosoi, Tokyo-Kita social insurance hospital).



[Figure ID: F2]
Figure 2 

Measurement of white blood cells (WBC), hematocrit (Hct) and C-reactive protein (CRP).



[Figure ID: F3]
Figure 3 

Percentage of neutrophils in the white blood cells (WBC) of the peripheral blood.



Tables
[TableWrap ID: T1] Table 1 

Laboratory data of all hereditary angioedema (HAE) patients (at first visit without symptoms)


Patient no. C3 (mg/dL) C4 (mg/dL) CH5O (U/mL) Cl-INH
WBC (/μL) RBC (×104/L) Htc (%) CRP (mg/dL)
Function (%) Antigen (mg/dl)
Normal range
69-128
14-36
25-54
70-130
11-26
3600-8900
380-504
35.6-45.4
<0.2
1
159
3
24.2
35
n.t.
7100
512
42.2
2.1
2
103
<2
9.7
<25
7
5100
414
39.1
0.3
3
100
9
39
30
<6
4100
487
43.8
0.2
4
140
5
33.4
29
10
4900
430
39.2
0.7
5
93
3
22.9
<25
n.t.
5900
475
43.6
0.1
6
106
7
33
29
8
7800
454
40.7
0.2
7
105
3
27
<25
<6
7700
490
44.7
0.4
8
n.t.
n.t.
n.t.
n.t.
n.t.
n.t.
n.t.
n.t.
n.t.
9
97
4
25.8
<25
7
6100
462
39.9
0.2
10
97
5
25.1
<25
<6
8400
470
43.2
0.1
11
112
10
51.5
39
14
9700
432
41.6
0.1
12
124
8
46
<25
n.t.
7000
526
47.1
0.1
13
95
9
33
33
10
3800
470
43.2
0.0
14 67 10 32.3 34 15 5600 365 36.1 0.0

C1-INH C1 inhibitor, CH50 total hemolytic complement; CRP C-reactive protein, Hct hematocrit, n.t. not tested, RBC red blood cell, WBC white blood cell.


[TableWrap ID: T2] Table 2 

Total frequencies of emergency department visits, affected organs and treatment


Total frequency of visits 31  
  C1-inhibitors concentrate
28
 
   GI tract
17
 
      GI tract
 
16
      GI tract + Neck
 
1
   Others
11
 
      Lips
 
3
      Extremities
 
3
      Cheek
 
2
      Face
 
1
      Face + Neck + Hand
 
1
      Shoulder + Larynx
 
1
  Tranexamic acid
1
 
   Foot
 
1
  Observation (No medication)
2
 
   Lips
 
1
   Foot   1

GI-tract gastrointestinal tract.



Article Categories:
  • Research Article

Keywords: Hereditary angioedema, C1-inhibitor, C1-inhibitor concentrate, Acute abdomen, Leukocytosis, Hemoconcentration.

Previous Document:  What supports do health system organizations have in place to facilitate evidence-informed decision-...
Next Document:  Cell surface engineering of microorganisms towards adsorption of heavy metals.